Compare Stocks: ACU, QDEL, CERS, and EMBC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACU Acme United	$61.80 -0.1%	$56.05	$35.50 ▼ $64.17	$235.45M	0.49	20,442 shs	5,681 shs
CERS Cerus	$2.50 -0.6%	$2.80	$1.19 ▼ $3.47	$502.79M	1.8	2.17 million shs	203,901 shs
EMBC Embecta	$4.94 -3.6%	$4.26	$2.77 ▼ $15.55	$280.01M	0.86	1.57 million shs	294,048 shs
QDEL QuidelOrtho	$12.49 -1.2%	$15.78	$9.92 ▼ $35.58	$857.06M	0.68	1.71 million shs	207,183 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACU Acme United	+1.18%	-3.10%	+9.32%	+35.97%	+44.82%
CERS Cerus	-1.18%	-3.46%	-0.40%	-3.09%	+94.57%
EMBC Embecta	-7.75%	-10.02%	+2.61%	+66.23%	-66.38%
QDEL QuidelOrtho	-5.53%	-9.39%	-8.07%	-10.29%	-55.74%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACU Acme United	$61.80 -0.1%	$56.05	$35.50 ▼ $64.17	$235.45M	0.49	20,442 shs	5,681 shs
CERS Cerus	$2.50 -0.6%	$2.80	$1.19 ▼ $3.47	$502.79M	1.8	2.17 million shs	203,901 shs
EMBC Embecta	$4.94 -3.6%	$4.26	$2.77 ▼ $15.55	$280.01M	0.86	1.57 million shs	294,048 shs
QDEL QuidelOrtho	$12.49 -1.2%	$15.78	$9.92 ▼ $35.58	$857.06M	0.68	1.71 million shs	207,183 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACU Acme United	+1.18%	-3.10%	+9.32%	+35.97%	+44.82%
CERS Cerus	-1.18%	-3.46%	-0.40%	-3.09%	+94.57%
EMBC Embecta	-7.75%	-10.02%	+2.61%	+66.23%	-66.38%
QDEL QuidelOrtho	-5.53%	-9.39%	-8.07%	-10.29%	-55.74%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACU Acme United	4.00	Strong Buy	N/A	N/A
CERS Cerus	2.40	Hold	$5.25	110.42% Upside
EMBC Embecta	1.60	Reduce	$11.00	122.81% Upside
QDEL QuidelOrtho	1.50	Reduce	$13.63	9.08% Upside

Current Analyst Ratings Breakdown

Latest ACU, QDEL, CERS, and EMBC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/20/2026	CERS Cerus	Freedom Broker Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$6.50
8/12/2026	QDEL QuidelOrtho	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/3/2026	EMBC Embecta	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
7/17/2026	QDEL QuidelOrtho	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	EMBC Embecta	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/8/2026	QDEL QuidelOrtho	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$13.00 ➝ $18.00
7/1/2026	QDEL QuidelOrtho	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Underweight	$11.00 ➝ $12.00
6/29/2026	QDEL QuidelOrtho	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold
6/18/2026	CERS Cerus	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
6/15/2026	QDEL QuidelOrtho	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold

(Data available from 9/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACU Acme United	$211.60M	1.11	$6.17 per share	10.02	$27.31 per share	2.26
CERS Cerus	$206.13M	2.44	N/A	N/A	$0.34 per share	7.34
EMBC Embecta	$1.08B	0.26	$3.55 per share	1.39	($11.12) per share	-0.44
QDEL QuidelOrtho	$2.73B	0.31	$17.59 per share	0.71	$28.27 per share	0.44

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACU Acme United	$17.79M	$2.38	12.64	N/A	N/A	10.25%	9.70%	6.10%	N/A
CERS Cerus	-$15.63M	-$0.03	N/A	N/A	N/A	-3.06%	-10.19%	-3.14%	11/5/2026 (Estimated)
EMBC Embecta	$95.40M	$1.48	3.34	2.81	N/A	8.59%	-19.25%	10.82%	11/24/2026 (Estimated)
QDEL QuidelOrtho	-$1.13B	-$15.41	N/A	8.50	N/A	-39.20%	4.88%	1.63%	11/4/2026 (Estimated)

Latest ACU, QDEL, CERS, and EMBC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2026	Q3 2026	EMBC Embecta	$0.2658	$0.56	+$0.2942	$0.36	$254.53 million	$271.70 million
8/6/2026	Q2 2026	QDEL QuidelOrtho	-$0.0488	$0.13	+$0.1788	-$1.36	$618.72 million	$630.90 million
7/30/2026	Q2 2026	CERS Cerus	-$0.0133	-$0.01	+$0.0033	-$0.01	$62.90 million	$63.30 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACU Acme United	$0.64	1.04%	+5.25%	26.89%	20 Years
CERS Cerus	N/A	N/A	N/A	N/A	N/A
EMBC Embecta	$0.04	0.81%	N/A	2.70%	N/A
QDEL QuidelOrtho	N/A	N/A	N/A	N/A	N/A

Latest ACU, QDEL, CERS, and EMBC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/4/2026	EMBC Embecta	quarterly	$0.01	0.8%	8/27/2026	8/27/2026	9/15/2026
6/17/2026	ACU Acme United	quarterly	$0.16	1.34%	7/2/2026	7/2/2026	7/23/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACU Acme United	0.30	4.41	1.91
CERS Cerus	0.49	1.83	1.07
EMBC Embecta	N/A	1.68	1.17
QDEL QuidelOrtho	1.43	1.39	0.76

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ACU Acme United	62.10%
CERS Cerus	78.37%
EMBC Embecta	93.83%
QDEL QuidelOrtho	99.00%

Insider Ownership

Company	Insider Ownership
ACU Acme United	29.50%
CERS Cerus	5.30%
EMBC Embecta	1.30%
QDEL QuidelOrtho	1.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ACU Acme United	650	3.81 million	2.50 million	Not Optionable
CERS Cerus	290	201.52 million	190.84 million	Optionable
EMBC Embecta	1,850	56.66 million	55.92 million	Optionable
QDEL QuidelOrtho	6,500	68.57 million	67.82 million	Optionable

ACU, QDEL, CERS, and EMBC Headlines

Recent News About These Companies

Legal & General Group Plc Acquires New Stake in QuidelOrtho Corporation $QDEL

September 6, 2026 | marketbeat.com

QDEL stock gains as QuidelOrtho beats estimates and trades near target

September 5, 2026 | ad-hoc-news.deA

Bank of New York Mellon Corp Purchases New Stake in QuidelOrtho Corporation $QDEL

September 4, 2026 | marketbeat.com

Empowered Funds LLC Purchases Shares of 267,989 QuidelOrtho Corporation $QDEL

September 1, 2026 | marketbeat.com

QuidelOrtho Corporation $QDEL Shares Bought by Newtyn Management LLC

August 31, 2026 | marketbeat.com

Private Management Group Inc. Acquires 685,622 Shares of QuidelOrtho Corporation $QDEL

August 30, 2026 | marketbeat.com

Deutsche Bank AG Invests $1.62 Million in QuidelOrtho Corporation $QDEL

August 29, 2026 | marketbeat.com

BlackRock Inc. Takes Position in QuidelOrtho Corporation $QDEL

August 28, 2026 | marketbeat.com

Faster Answers, Better Decisions: ADLM 2026 Highlights

August 27, 2026 | prnewswire.com

J.P. Morgan Sticks to Its Sell Rating for QuidelOrtho (QDEL)

August 25, 2026 | theglobeandmail.com

Paradigm Capital Management Inc. NY Makes New Investment in QuidelOrtho Corporation $QDEL

August 25, 2026 | marketbeat.com

QuidelOrtho Corporation (NASDAQ:QDEL) Receives Consensus Rating of "Reduce" from Analysts

August 23, 2026 | marketbeat.com

QuidelOrtho (NASDAQ:QDEL) Stock Price Down 3.4% - Should You Sell?

August 21, 2026 | marketbeat.com

Tejara Capital Ltd Takes $2.27 Million Position in QuidelOrtho Corporation $QDEL

August 21, 2026 | marketbeat.com

QuidelOrtho (NASDAQ:QDEL) Shares Up 6.9% - Here's What Happened

August 20, 2026 | marketbeat.com

QuidelOrtho Earnings Call Balances Resilience And Risk

August 18, 2026 | tipranks.com

Rice Hall James & Associates LLC Invests $18.63 Million in QuidelOrtho Corporation $QDEL

August 18, 2026 | marketbeat.com

QuidelOrtho (QDEL) Is Up 6.0% After Cutting 2026 Revenue Outlook Amid Narrowing Losses – What's Changed

August 18, 2026 | finance.yahoo.com

QDEL's 2026 Outlook Cut Deepens China and Respiratory Risk Concerns

August 17, 2026 | zacks.com

Is QDEL Worth Buying as China Risks Clash With Resilient Core Growth?

August 17, 2026 | zacks.com

QDEL Rallies 31.7% in Three Months: Can the Stock Keep Climbing Higher?

August 17, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ACU, QDEL, CERS, and EMBC Company Descriptions

Acme United NYSE:ACU

$61.80 -0.04 (-0.07%)

As of 11:36 AM Eastern

Acme United Corporation supplies cutting, measuring, first aid, and sharpening products to the school, home, office, hardware, sporting goods, and industrial markets in the United States, Canada, Europe, and internationally. The company offers scissors, shears, knives, rulers, pencil sharpeners, paper trimmers, safety cutters, lettering products, glue guns, and other craft products under the Westcott brand name; and cutting tools under the Clauss brand. It also provides sharpening knives, scissors, chisels, skis, skates, and other edge under the DMT brand. In addition, the company offers first aid kit and safety solutions under the First Aid Only brand; portable eyewash solution and over-the-counter medication, including active ingredients aspirin, acetaminophen, and ibuprofen under the PhysiciansCare brand; bodily fluid and spill clean-up solution under the Spill Magic brand; various first aid kit, refill, and safety supplies, including CPR kits, burn kits, and automotive and emergency first aid kits under the First Aid Central; first aid kits for the promotional products industry under Safety Made brand; and alcohol prep pads, alcohol wipes, benzalkonium chloride wipes, various antiseptic wipes, castile soaps, and lens cleaning wipes under the Med-Nap brand. It sells its products directly and through its independent manufacturer representatives to wholesale, contract, and retail stationery distributors; office supply super stores, mass market retailers, industrial and medical distributors, school supply distributors, drug store retailers, sporting goods stores, hardware chains, and wholesale florists, as well as through its websites. The company was formerly known as Acme Shear Company and changed its name to Acme United Corporation in 1971. Acme United Corporation was founded in 1867 and is based in Shelton, Connecticut.

Cerus NASDAQ:CERS

$2.50 -0.02 (-0.60%)

As of 11:38 AM Eastern

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.

Embecta NASDAQ:EMBC

$4.94 -0.18 (-3.57%)

As of 11:38 AM Eastern

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

QuidelOrtho NASDAQ:QDEL

$12.49 -0.15 (-1.18%)

As of 11:38 AM Eastern

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ACU, QDEL, CERS, and EMBC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ACU, QDEL, CERS, and EMBC Earnings

Compare Dividends

Latest ACU, QDEL, CERS, and EMBC Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ACU, QDEL, CERS, and EMBC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ACU, QDEL, CERS, and EMBC Company Descriptions

Acme United NYSE:ACU

Cerus NASDAQ:CERS

Embecta NASDAQ:EMBC

QuidelOrtho NASDAQ:QDEL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools